CARGO Therapeutics

Cargo Therapeutics

Biotechnology, 1900 Alameda De Las Pulgas, San Mateo, California, 94402, United States, 11-50 Employees

cargo-tx.com

  • LinkedIn

Who is CARGO THERAPEUTICS

CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potenti...

Read More

map
  • 1900 Alameda De Las Pulgas, San Mateo, California, 94402, United States Headquarters: 1900 Alameda De Las Pulgas, San Mateo, California, 94402, United States
  • 2021 Date Founded: 2021
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from CARGO THERAPEUTICS

CARGO Therapeutics Org Chart and Mapping

Employees

Kato S

Director of Quality Control

Jared Clever

Director, Gene Delivery Technology Development

Jocelyn Chapman

Executive Business Parter

Yue Yuan

Process Development Engineer

Mary Rodley

Executive Director, Cmc Operations & Strategy

Jacqueline Geyfen

Senior Research Associate, Translational Medicine

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding CARGO Therapeutics

Answer: CARGO Therapeutics's headquarters are located at 1900 Alameda De Las Pulgas, San Mateo, California, 94402, United States

Answer: CARGO Therapeutics's official website is https://cargo-tx.com

Answer: CARGO Therapeutics's revenue is Under $1 Million

Answer: CARGO Therapeutics has 11-50 employees

Answer: CARGO Therapeutics is in Biotechnology

Answer: CARGO Therapeutics contact info: Phone number: Website: https://cargo-tx.com

Answer: CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies. CARGO is on a mission to outsmart cancer by advancing a new generation of best-in-class chimeric antigen receptor (CAR) T-cell therapies. Despite advances made by commercially available autologous CARs, these treatments are curative for fewer than half of all cancer patients. In addition, far too many patients are unable to access these potentially curative therapies due to other challenges, including manufacturing, supply constraints, slow turnaround time and reimbursement hurdles. The team at CARGO is intensely focused on pursuing novel solutions to achieve better cancer treatment outcomes and experiences.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access